Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
ResMed Inc. Common Stock
(NY:
RMD
)
278.59
+1.95 (+0.70%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ResMed Inc. Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Align Technology, ResMed, Insulet, Envista, and Dentsply Sirona Shares Plummet, What You Need To Know
September 25, 2025
A number of stocks fell in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential...
Via
StockStory
Topics
World Trade
Which S&P500 stocks are gapping on Thursday?
September 25, 2025
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Thursday to find the gap up and gap down stocks in today's session.
Via
Chartmill
ResMed Inc. (NYSE:RMD) Offers a Reliable Dividend with Strong Financial Health
September 25, 2025
Learn how ResMed (RMD) exemplifies a strong dividend stock with a 10+ year growth streak, a low payout ratio, and robust profitability for reliable passive income.
Via
Chartmill
1 Cash-Producing Stock to Target This Week and 2 We Turn Down
September 23, 2025
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Via
StockStory
ResMed Stock: A Deep Dive Into Analyst Perspectives (9 Ratings)
September 18, 2025
Via
Benzinga
This Progressive Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday
September 18, 2025
Via
Benzinga
This Target Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday
September 18, 2025
Via
Benzinga
1 Profitable Stock for Long-Term Investors and 2 Facing Headwinds
September 17, 2025
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Via
StockStory
Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025
September 16, 2025
From
Resmed, Inc.
Via
GlobeNewswire
Q2 Earnings Outperformers: ResMed (NYSE:RMD) And The Rest Of The Patient Monitoring Stocks
September 11, 2025
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at patient monitoring stocks, starting with...
Via
StockStory
Topics
Artificial Intelligence
ResMed, Insulet, Lantheus, Inspire Medical Systems, and Evolent Health Shares Plummet, What You Need To Know
September 10, 2025
A number of stocks fell in the afternoon session after markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflation reading.
Via
StockStory
Topics
Economy
Top S&P500 movers in Wednesday's session
September 10, 2025
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday.
Via
Chartmill
These S&P500 stocks are gapping in today's session
September 10, 2025
Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Wednesday. Discover the gap up and gap down stocks in the S&P500 index.
Via
Chartmill
Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority
September 03, 2025
New global clinical insights initiative debuts at World Sleep Congress 2025 to help drive innovation in sleep health care
From
Resmed, Inc.
Via
GlobeNewswire
ResMed Inc. (NYSE:RMD): A Top Dividend Stock for Sustainable Income and Growth
September 01, 2025
ResMed (RMD) is a top dividend stock with a low payout ratio, strong financial health, and consistent growth, ensuring sustainable income for investors.
Via
Chartmill
2 S&P 500 Stocks to Target This Week and 1 That Underwhelm
August 28, 2025
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth,...
Via
StockStory
Topics
Stocks
3 Reasons Investors Watch ResMed (RMD)
August 28, 2025
ResMed has had an impressive run over the past six months as its shares have beaten the S&P 500 by 11.9%. The stock now trades at $281.96, marking a 20.7% gain. This was partly due to its solid...
Via
StockStory
Topics
Government
Stocks
These S&P500 stocks are gapping in today's session
August 27, 2025
Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Wednesday. Discover the gap up and gap down stocks in the S&P500 index.
Via
Chartmill
Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds
August 27, 2025
Published in The Lancet Respiratory Medicine, research reveals sharp rise in OSA, especially among women, highlighting the need for earlier diagnosis, preventative strategies, and personalized care
From
Resmed, Inc.
Via
GlobeNewswire
1 Mooning Stock to Target This Week and 2 We Brush Off
August 26, 2025
Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions.
Via
StockStory
Resmed Strengthens Innovation Leadership with Dual Red Dot Design Awards and 10,000 Patents and Designs
August 21, 2025
Milestones underscore Resmed’s leadership and commitment to delivering life-changing health technology that people love
From
Resmed, Inc.
Via
GlobeNewswire
Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio
August 18, 2025
From
Resmed, Inc.
Via
GlobeNewswire
RMD Q2 Deep Dive: Margin Expansion and Product Innovation Drive Outperformance
August 12, 2025
Medical device company ResMed (NYSE:RMD) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 10.2% year on year to $1.35 billion. Its non-GAAP profit of $2.55 per share...
Via
StockStory
Topics
Artificial Intelligence
Economy
ResMed Inc (NYSE:RMD): A Strong Dividend Stock with Growth Potential and Financial Stability
August 09, 2025
ResMed (RMD) offers a strong dividend with steady growth, backed by solid profitability and financial health, making it ideal for long-term income investors.
Via
Chartmill
Discover the top S&P500 movers in Tuesday's pre-market session.
August 05, 2025
Stay updated with the S&P500 stocks that are on the move in today's pre-market session.
Via
Chartmill
ResMed RMD Q4 2025 Earnings Call Transcript
August 04, 2025
Via
The Motley Fool
Topics
Earnings
Stay informed with the top movers within the S&P500 index on Monday.
August 04, 2025
Curious about the S&P500 stocks that are in motion on Monday? Join us as we explore the top movers within the S&P500 index during today's session.
Via
Chartmill
The Analyst Verdict: ResMed In The Eyes Of 8 Experts
August 01, 2025
Via
Benzinga
ResMed Analysts Increase Their Forecasts After Strong Q2 Earnings
August 01, 2025
Via
Benzinga
ResMed (RMD) Stock Is Up, What You Need To Know
August 01, 2025
Shares of medical device company ResMed (NYSE:RMD) jumped 3.1% in the afternoon session after the company reported strong fourth-quarter financial results that surpassed analyst estimates.
Via
StockStory
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.